Endoscopy Development Company has been sold to Healthcare Components Group, a portfolio company of RoundTable Healthcare Partners
Founded in 2003, EDC is a leading precision engineering and manufacturer of replacement and repair parts for flexible endoscopy equipment. The company has distribution in over 45 countries and offers over 1,200 components servicing a vast range of endoscope makes and models. The business is headquartered in Maryland Heights, Missouri, with approximately 100 employees globally.
The addition of EDC to the HCG family provides customers a true one-stop shop for all endoscopy components by bringing together two well-known leaders in both the optical and flexible categories. The combination of these businesses will lead to faster product releases as well as a more streamlined purchasing experience for HCG’s customers. Marcus Rosenberg, the current President of EDC, will serve in an expanded role as HCG’s President, Americas and Jeffrey Lay, EDC’s Co-founder, will remain an investor in the business and serve on the board of HCG.
Larry Hicks, Chief Executive Officer of HCG, stated, “This acquisition significantly enhances our offering to customers of components used in the development and repair of endoscopes and simultaneously provides an enhanced opportunity for career growth among a larger business for our employees.”
“We are excited to partner with HCG and RoundTable. We believe the combined product portfolio will allow us to better serve our customers,” commented, Marcus Rosenberg.
Cynthya Goulet, Managing Director in Lincoln’s Healthcare Group, commented, “We look forward to seeing the growth that HCG and EDC are capable of together. It was a pleasure to work with the EDC team through the transaction as they take the next step in the evolution of the business.”
Lincoln served as the exclusive financial advisor to EDC.
The Lincoln team truly made the process as efficient as possible and allowed us to focus on running our business.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.